Defective intracellular Ca2+ homeostasis contributes to myocyte dysfunction during ventricular remodelling induced by

Yan-Feng Ding1, Gregory L Brower, Qiao Zhong

  • 1Department of Anatomy, Physiology and Pharmacology, College of Veterinary Medicine, Auburn University, Auburn, Alabama 36849, USA.

Insights

Chronic volume overload impairs heart muscle cell function, leading to heart failure. This study shows reduced contractility and altered calcium handling in heart cells during this process.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Physiology

Background:

  • Previous studies show ventricular hypertrophy and dysfunction with chronic volume overload.
  • The role of intrinsic myocyte dysfunction in this decompensation remained unclear.

Purpose of the Study:

  • To evaluate ventricular myocyte function during progressive ventricular remodeling induced by volume overload.
  • To investigate the relationship between myocyte dysfunction and the transition to heart failure.

Main Methods:

  • Chronic volume overload induced via infrarenal aortocaval fistula in rats.
  • Myocyte contraction and intracellular calcium ([Ca(2+)](i)) assessed using fura-2 fluorescence and edge detection.
  • Sarcoplasmic reticulum (SR) Ca(2+) transporter protein levels determined by western blots.

Main Results:

  • Progressive ventricular dilatation observed post-fistula.
  • Myocyte function was comparable at 5 weeks but significantly depressed at 10 weeks post-fistula (reduced cell shortening and peak [Ca(2+)](i)).
  • Isoproterenol failed to normalize function; SR Ca(2+)-ATPase and ryanodine receptor expression were reduced at 10 weeks.

Conclusions:

  • Depressed myocyte contractility, stemming from altered intracellular calcium homeostasis, contributes to the transition to heart failure in chronic volume overload.
  • Reduced SR Ca(2+) transporter function is implicated in the myocyte dysfunction observed.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...